stockrowIncyte Corporation (INCY) vs Jazz Pharmaceuticals PLC (JAZZ)
- Incyte Corporation INCY 121.89 −0.31%
- Jazz Pharmaceuticals PLC JAZZ 242.04 −2.50%
Incyte Corporation and Jazz Pharmaceuticals PLC are both Biotechnology companies. Incyte Corporation is the larger, with a market value of $24.9B against $15.9B — 1.6× the size. Incyte Corporation trades at the lower P/E: 58.1× against 66.5×. Incyte Corporation grew revenue faster over the last twelve months: 24.9% against 13.5%. Incyte Corporation has the higher net margin (6.71% vs 4.36%) and the higher return on invested capital (21.6% vs 3.86%). Across the 21 metrics below, Incyte Corporation leads on 15 and Jazz Pharmaceuticals PLC on 6.
Valuation
Profitability
| Metric | INCY | JAZZ | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.69% | 89.09% | 68.27% |
| Operating margin | 10.42% | 9.03% | 0.00% |
| Net margin | 6.71% | 4.36% | 0.00% |
| Free cash flow margin | 11.31% | 32.27% | 0.00% |
| Return on equity | 7.84% | 5.05% | (50.82%) |
| Return on assets | 5.92% | 1.76% | (46.08%) |
| Return on invested capital | 21.56% | 3.86% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack